AG0080HY

129618-40-2 | Nevirapine

Chemical structure of Nevirapine, CAS 129618-40-2
AG0080HY
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 129618-40-2
Catalog Number AG0080HY(AGN-PC-07A24E)
Chemical Name Nevirapine
EC Number 603-345-0
IUPAC Name 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
InChI InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)
InChI Key NQDJXKOVJZTUJA-UHFFFAOYSA-N
MDL Number MFCD00866928
Molecular Formula C15H14N4O
Molecular Weight 266.2979
SMILES O=C1C2=CC=CN=C2N(C3CC3)C4=NC=CC(C)=C4N1
UNII 99DK7FVK1H
Synonyms
BI RG 587, BI-RG-587, BIRG587, Hemihydrate, Nevirapine, Nevirapine, Nevirapine Hemihydrate, Viramune, nevirapine, 129618-40-2, Viramune, BI-RG-587, Viramune XR, NVP, BIRG 0587, 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, UNII-99DK7FVK1H, 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE, Nevirapine anhydrous, 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, Nevirapine (Viramune), BI-RG 587, BIRG-0587, HSDB 7164, CHEMBL57, NEV, NSC 641530, 99DK7FVK1H, 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one, 11-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6(11H)-ONE, MLS000084585, NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE, C15H14N4O, CHEBI:63613, NQDJXKOVJZTUJA-UHFFFAOYSA-N, Nevirapine, 98%, MFCD00866928, NSC641530, 6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-, NCGC00065890-02, SMR000048458, DSSTox_CID_10787, DSSTox_RID_78889, DSSTox_GSID_31797, 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one, BIRG587, Nevirapine [USAN:INN], Viramune(TM), Viramune (TN), CAS-129618-40-2, Nevirapine & CD4-IgG, Nevirapine & PRO 140, Nevirapine (JAN/USP/INN), 11-cyclopropyl-4-methyl-5H-dipyrido[[?],[?]][1,4]diazepin-6-one, BIRG 587, BIRG-587, 11-cyclopropyl-4-methyl-5H-dipyrido[2,3-b:3',2'-e][1,4]diazepin-6-one, Viramune IR, 1vrt, 2hny, Nevirapine,(S), Nevirapine [USAN:USP:INN:BAN], BI-RG-587 & CD4-IgG, Opera_ID_934, Viramune;BI-RG 587, SCHEMBL3318, MLS000759409, MLS001055309, MLS001201730, MLS001424058, MLS006011423, BIDD:GT0326, AC1L1I81, BDBM1434, ZINC4778, DTXSID7031797, CTK8E7455, KS-00000KZF, HMS2051J09, HMS2231O23, HMS3264D21, HMS3371E03, HMS3393J09, HMS3655I08, HMS3715B10, Pharmakon1600-01503842, ALBB-027264, BCP05587, Tox21 110982, Tox21_110982, Tox21_200770, AC-643, BBL010768, NSC759902, STK580320, AKOS005504351, Tox21_110982_1, AB07544, CCG-100939, CS-2252, DB00238, KS-5019, LS-2289, MCULE-8608154492, NC00189, NSC-641530, NSC-759902, RL01415, NCGC00065890-03, NCGC00065890-04, NCGC00065890-05, NCGC00065890-07, NCGC00258324-01, 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody), AJ-08226, AK143126, AN-15635, BC206673, CPD000048458, H954, HY-10570, N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin, SAM001246551, SC-17266, SY009679, ZB000592, AB0013383, AB2000266, RT-014690, FT-0607215, N0922, R3924, S1742, ST24038235, SW197569-2, 11-Cyclopropyl-4-methyl-5H-dipyrido[3,2-b, MFCD00866928 (98%), C07263, D00435, AB00393001-13, AB00393001-15, AB00393001_16, AB00393001_17, 618N402, I02-0310, F2173-0607, Z1695906730, Nevirapine (anhydrous), European Pharmacopoeia (EP) Reference Standard, Nevirapine anhydrous, United States Pharmacopeia (USP) Reference Standard, Nevirapine solution, 1.0 mg/mL in methanol, certified reference material, Nevirapine, Pharmaceutical Secondary Standard; Certified Reference Material, 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido-[3,2-b:2',3'-e][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b :2',3'-e][1,4 ]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one, 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2', 3'-e][1,4]diazepin-6-one, 5H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 5,11-dihydro-11-cyclopropyl-4-methyl-, 6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-, Nevirapine for peak identification, European Pharmacopoeia (EP) Reference Standard, 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2 inverted exclamation mark ,3 inverted exclamation mark -e][1,4]diazepin-6-one, 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0(3),]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one, 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0;{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one, Netobimin, Nevirapine hemihydrate, NEVARAPINE, Hemihydrate, Nevirapine, D0O2EM, Promeco Brand of Nevirapine, BI RG 587, CID4463, DRG-0116, Viramune, BI-RG 587, Nevirapine, C15-H14-N4-O, Cahill May Roberts Brand of Nevirapine, CS-O-01945, A8481, A10639, D019829, Nevirapine, 99%, Non-nucleoside reverse transcriptase inhibitor (NNRTI) - 100MG 100mg,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited